Dynamic Susceptibility Contrast MRI for Evaluation of Patients With High-Grade Glioma: Need for Multicenter Clinical Trial Validation.
Publication
, Journal Article
Barboriak, DP
Published in: AJR Am J Roentgenol
January 28, 2026
Duke Scholars
Published In
AJR Am J Roentgenol
DOI
EISSN
1546-3141
Publication Date
January 28, 2026
Start / End Page
1
Location
United States
Related Subject Headings
- Nuclear Medicine & Medical Imaging
- 3202 Clinical sciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Barboriak, D. P. (2026). Dynamic Susceptibility Contrast MRI for Evaluation of Patients With High-Grade Glioma: Need for Multicenter Clinical Trial Validation. AJR Am J Roentgenol, 1. https://doi.org/10.2214/AJR.25.32940
Barboriak, Daniel P. “Dynamic Susceptibility Contrast MRI for Evaluation of Patients With High-Grade Glioma: Need for Multicenter Clinical Trial Validation.” AJR Am J Roentgenol, January 28, 2026, 1. https://doi.org/10.2214/AJR.25.32940.
Barboriak DP. Dynamic Susceptibility Contrast MRI for Evaluation of Patients With High-Grade Glioma: Need for Multicenter Clinical Trial Validation. AJR Am J Roentgenol. 2026 Jan 28;1.
Barboriak, Daniel P. “Dynamic Susceptibility Contrast MRI for Evaluation of Patients With High-Grade Glioma: Need for Multicenter Clinical Trial Validation.” AJR Am J Roentgenol, Jan. 2026, p. 1. Pubmed, doi:10.2214/AJR.25.32940.
Barboriak DP. Dynamic Susceptibility Contrast MRI for Evaluation of Patients With High-Grade Glioma: Need for Multicenter Clinical Trial Validation. AJR Am J Roentgenol. 2026 Jan 28;1.
Published In
AJR Am J Roentgenol
DOI
EISSN
1546-3141
Publication Date
January 28, 2026
Start / End Page
1
Location
United States
Related Subject Headings
- Nuclear Medicine & Medical Imaging
- 3202 Clinical sciences
- 1103 Clinical Sciences